Precigen
PGEN
150 hedge funds and large institutions have $926M invested in Precigen in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 57 increasing their positions, 35 reducing their positions, and 27 closing their positions.
63% more repeat investments, than reductions
Existing positions increased: 57 | Existing positions reduced: 35
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
1.24% less ownership
Funds ownership: 70.07% → 68.83% (-1.2%)
5% less capital invested
Capital invested by funds: $979M → $926M (-$52.3M)
10% less funds holding
Funds holding: 166 → 150 (-16)
11% less call options, than puts
Call options by funds: $5.4M | Put options by funds: $6.05M
56% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 27
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$5.7M |
| 2 |
TS
Third Security
Radford,
Virginia
|
+$3.96M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.95M |
| 4 |
JP Morgan Chase
New York
|
+$2.84M |
| 5 |
Morgan Stanley
New York
|
+$2.36M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$8.08M |
| 2 |
D.E. Shaw & Co
New York
|
-$3.52M |
| 3 |
Millennium Management
New York
|
-$2.61M |
| 4 |
GCM
Graham Capital Management
Rowayton,
Connecticut
|
-$2.13M |
| 5 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
-$1.9M |
PGEN Hedge Fund Activity: Q2 2021 in Review
150 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q2 2021, worth a combined $926M — down 5.3% from $979M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of PGEN and 12 opened new positions — a net loss of 15 holders — while 35 trimmed existing stakes and 57 added.
The largest buyer was Citadel Advisors, adding an estimated $5.7M. The largest seller was State Street, cutting an estimated $8.08M.
- 150 institutional investors held Precigen (PGEN) as of Q2 2021, down from 166 in Q1 2021.
- Funds reported $926M of Precigen stock for Q2 2021, down 5.3% quarter-over-quarter.
- 12 funds opened new Precigen positions in Q2 2021 and 27 closed out, a net change of -15 holders.
- The largest Precigen buyer in Q2 2021 was Citadel Advisors, an estimated $5.7M added.
- The largest Precigen seller in Q2 2021 was State Street, an estimated $8.08M sold.
Based on aggregated 13F filings for Q2 2021.